The Utilities of Estrogen Receptor, Cytokeratin 5/6, and Cytokeratin 903 to Differentiate Between Usual Ductal Hyperplasia, Flat Epithelial Atypia, Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Lobular Carcinoma In Situ

被引：0
|
作者：
Wei, Eric [1 ]
Dela Cruz, Nestor [1 ]
机构：
[1] LSU Hlth Sci Ctr, New Orleans, LA USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2018年 / 149卷
关键词：
D O I：
10.1093/ajcp/aqx116.067
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
68
引用
收藏
页码：S30 / S30
页数：1
相关论文
共 50 条
  • [41] ATYPICAL DUCTAL HYPERPLASIA DUCTAL CARCINOMA IN-SITU ASSOCIATED WITH MUCOCELE-LIKE TUMORS OF THE BREAST
    BLUTH, RF
    PAGE, DL
    JENSEN, RA
    LABORATORY INVESTIGATION, 1995, 72 (01) : A15 - A15
  • [42] Computational Image Analysis of Nuclear Morphology Distinguishes Ductal Carcinoma In Situ from Usual Ductal Hyperplasia of the Breast
    Dong, F.
    Lerwill, M. F.
    Brachtel, E. F.
    Knoblauch, N. W.
    Montaser-Kouhsari, L.
    Jones, N. C.
    Wilbur, D. C.
    Beck, A. H.
    MODERN PATHOLOGY, 2014, 27 : 45A - 46A
  • [43] Computational Image Analysis of Nuclear Morphology Distinguishes Ductal Carcinoma In Situ from Usual Ductal Hyperplasia of the Breast
    Dong, F.
    Lerwill, M. F.
    Brachtel, E. F.
    Knoblauch, N. W.
    Montaser-Kouhsari, L.
    Jones, N. C.
    Wilbur, D. C.
    Beck, A. H.
    LABORATORY INVESTIGATION, 2014, 94 : 45A - 46A
  • [44] Transitions Between Flat Epithelial Atypia and Low-grade Ductal Carcinoma In Situ of the Breast
    Aulmann, Sebastian
    Braun, Lisa
    Mietzsch, Friederike
    Longerich, Thomas
    Penzel, Roland
    Schirmacher, Peter
    Sinn, Hans Peter
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (08) : 1247 - 1252
  • [45] Prediction of underestimation associated with flat epithelial atypia, atypical ductal hyperplasia and atypical lobular hyperplasia by needle biopsy: Experience in an Argentine breast unit
    Calvo, M. F.
    Allemand, C.
    Valerio, A. C.
    Hernandez, M. N.
    Corrao, F. H.
    Castro Barba, M.
    Wernicke, A.
    Orti, R.
    Ilzarbe, F.
    Gogorza, S. J.
    Albrecht, A.
    Izbizky, G. H.
    Lorusso, C.
    CANCER RESEARCH, 2017, 77
  • [46] Atypical Ductal Hyperplasia and Those Bordering on Ductal Carcinoma In Situ Should Be Included in the Active Surveillance Clinical Trials
    Khoury, Thaer
    Jabbour, Nashwan
    Peng, Xuan
    Yan, Li
    Quinn, Marie
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 153 (01) : 131 - 138
  • [47] Atypical Ductal Hyperplasia and Those Boarding on Ductal Carcinoma in Situ Should be Included in the Active Surveillance Clinical Trials
    Khoury, Thaer
    Jabbour, Nashwan
    Peng, Xuan
    Yan, Li
    Quinn, Marie
    MODERN PATHOLOGY, 2019, 32
  • [48] Atypical Ductal Hyperplasia and Those Boarding on Ductal Carcinoma in Situ Should be Included in the Active Surveillance Clinical Trials
    Khoury, Thaer
    Jabbour, Nashwan
    Peng, Xuan
    Yan, Li
    Quinn, Marie
    LABORATORY INVESTIGATION, 2019, 99
  • [49] Can mammographic findings help discriminate between atypical ductal hyperplasia and ductal carcinoma in situ after needle core biopsy?
    Hoang, Jenny K.
    Hill, Prue
    Cawson, Jennifer N.
    BREAST, 2008, 17 (03): : 282 - 288
  • [50] Comparison of rate limiting factors in the transformation of atypical ductal hyperplasia and ductal carcinoma in situ of the breast using immunochemistry and fluorescence in situ hybridization
    Turbat-Herrera, EA
    Nordberg, ML
    deBenedetti, A
    Lampejo, OT
    MODERN PATHOLOGY, 2003, 16 (01) : 50A - 50A
12345